We use cookies to ensure that we give you the best experience on our website. By continuing to browse the site you are agreeing to our use of cookies. If you would like to know more please click here.


The Cyclofluidic technology platform CyclOps™ is based on ground breaking research developed in the laboratories of Professor Steve Ley at Cambridge University and at GlaxoSmithKline. Cyclofluidic was set up to commercialise these discoveries with a collaborative research grant from the UK Government Technology Strategy Board and additional funding from pharmaceutical companies UCB and Pfizer.

The company has been developing the technology at laboratories in Welwyn Garden City UK since early 2009 and is now operating a collaborations business to exploit the power of the technology with its partners in all discovery sectors.